Skip to main content
. 2020 Oct 6;113(1):172–178. doi: 10.1093/ajcn/nqaa278

TABLE 3.

Threshold at which teduglutide becomes <$100,000 per quality-adjusted life year gained for each parameter1

Parameter Base case Threshold value Change
Cost of medication $407,000/y $342,000/y Decrease by 16%
Probability of death on PN 18%/y 35%/y Increase by 94%
Cost of transplant $104,991 $940,325 Increase by 796%
Cost per CLABSI admission $30,094 $169,497 Increase by 463%

1CLABSI, central line-associated bloodstream infection; PN, parenteral nutrition; QALY, quality-adjusted life year.